Average Co-Inventor Count = 15.29
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Signal Pharmaceuticals, Inc. (14 from 169 patents)
14 patents:
1. 11292796 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
2. 10683298 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
3. 10167290 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
4. 9771371 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
5. 9193692 - Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors
6. 9079900 - Methods of synthesis and purification of heteroaryl compounds
7. 8907087 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
8. 8569494 - Methods of synthesis and purification of heteroaryl compounds
9. 8507492 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway
10. 8492381 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
11. 8372976 - Methods of treatment comprising the administration of heteroaryl compounds
12. 8299056 - Aminotriazolopyridines, compositions thereof, and methods of treatment therewith
13. 8110578 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
14. 7981893 - Heteroaryl compounds, compositions thereof, and methods of treatment therewith